Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon‐like peptide‐1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Tito Borner, Ian C. Tinsley, Robert P. Doyle, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 542-556
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The past, present, and future physiology and pharmacology of glucagon
Megan E. Capozzi, David A. D’Alessio, Jonathan E. Campbell
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1654-1674
Open Access | Times Cited: 55
Weight loss efficiency and safety of tirzepatide: A Systematic review
Fei Lin, Bin Yu, Baodong Ling, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285197-e0285197
Open Access | Times Cited: 31
GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice
Zijun Chen, Xiaofei Deng, Cuijie Shi, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 10
Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus
David Aguilar-Recarte, Emma Barroso, Xavier Palomer, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 741-754
Closed Access | Times Cited: 28
The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1
Samantha M. Fortin, Jack Chen, Marisa Petticord, et al.
Science Advances (2023) Vol. 9, Iss. 38
Open Access | Times Cited: 17
GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?
Anders B. Klein, Maximilian Kleinert, Erik A. Richter, et al.
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 38
The efficacy of GLP‐1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review
David C Llewellyn, H Ellis, Simon Aylwin, et al.
Obesity (2022) Vol. 31, Iss. 1, pp. 20-30
Open Access | Times Cited: 25
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Kylie S. Chichura, Clinton Elfers, Therese S. Salameh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice
Naima S. Dahir, Yijun Gui, Yanan Wu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 14
Open Access | Times Cited: 4
European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management
Carolina Malagelada, Jutta Keller, Daniel Sifrim, et al.
United European Gastroenterology Journal (2025)
Open Access
Real-World Efficacy of Tirzepatide in Patients with Heart Failure without Diabetes
Silvio Nunes Augusto, David C. Kaelber, W.H. Wilson Tang
Current Problems in Cardiology (2025), pp. 102998-102998
Open Access
Liposomes Containing Tetraether Lipids and Cell‐Penetrating Peptides as Platform Technology for Oral Delivery of Peptides: A Comparative Study on GLP‐1 Analogs
Lorenz Herbster, Giulia Pander, Manuel Ben Böhmann, et al.
Nano Select (2025)
Open Access
Advances in small-molecule insulin secretagogues for diabetes treatment
Jingqian Su, Jingran Xu, Shan Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117179-117179
Open Access | Times Cited: 3
NASH Drug Development: Seeing the Light at the End of the Tunnel?
Yong Q. Chen
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 8
Optimal dose of tirzepatide for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis
Yunfeng Yu, Gang Hu, Shuang Yin, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 12
New developments in the prospects for GLP‐1 therapy
Stefan Trapp, S. Clare Stanford
British Journal of Pharmacology (2022) Vol. 179, Iss. 4, pp. 489-491
Open Access | Times Cited: 11
Reductions of food intake and body weight in diet-induced obese rats following chronic treatment with a monomeric peptide multiagonist
Clinton Elfers, Kylie S. Chichura, Emily F. Ashlaw, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1782-1790
Closed Access | Times Cited: 2
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
Long He, Qiuyu Li, Yongfeng Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis
Hani Raka Karrar, Mahmoud Ismail Nouh, Yousef Ismail Nouh, et al.
Cureus (2023)
Open Access | Times Cited: 6
Does glucose lowering restore GIP effects on insulin secretion?
Eleonora Grespan, Andrea Mari
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 3, pp. 494-499
Open Access | Times Cited: 4
Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice
Andrea S. Leuthardt, Christina N. Boyle, Kirsten Raun, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175912-175912
Open Access | Times Cited: 4
Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
Zhiqiang Ke, Qianqian Ma, Xiaonan Ye, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116471-116471
Closed Access | Times Cited: 1
Acute Pancreatitis Caused by Tirzepatide
Nur Mando, Erica Thomson, Matthew Fowler, et al.
Cureus (2024)
Open Access | Times Cited: 1
Inhibition of the melanocortin-3 receptor (MC3R) causes generalized sensitization to anorectic agents
Naima S. Dahir, Yijun Gui, Yanan Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top